The exact reconstitution calculations
The starting dose is 1 mg subcutaneously once weekly, regardless of body weight, prior experience, or goals
They are not applicable to retatrutide, which is an investigational product that has not completed the regulatory process in any jurisdiction
While a single dose of expired medication is unlikely to significantly impact weight loss progress, consistent use of degraded product could result in inadequate appetite suppression and failure to achieve weight management goals
Glucagon-like peptide 1 receptor agonists (GLP-1RAs), traditionally used in the treatment of type 2 diabetes, are becoming increasingly appreciated for their diverse applications
Retatrutide is an investigational once-weekly injectable drug that helped patients shed roughly a quarter of their body weight in trials results that approach the effectiveness of bariatric surgery